Aryl hydrocarbon receptor sulfenylation promotes glycogenolysis and rescues cancer chemoresistance

Elevation of reactive oxygen species (ROS) levels is a general consequence of tumor cells’ response to treatment and may cause tumor cell death. Mechanisms by which tumor cells clear fatal ROS, thereby rescuing redox balance and entering a chemoresistant state, remain unclear. Here, we show that cysteine sulfenylation by ROS confers on aryl hydrocarbon receptor (AHR) the ability to dissociate from the heat shock protein 90 complex but to bind to the PPP1R3 family member PPP1R3C of the glycogen complex in drug-treated tumor cells, thus activating glycogen phosphorylase to initiate glycogenolysis and the subsequent pentose phosphate pathway, leading to NADPH production for ROS clearance and chemoresistance formation. We found that basic ROS levels were higher in chemoresistant cells than in chemosensitive cells, guaranteeing the rapid induction of AHR sulfenylation for the clearance of excess ROS. These findings reveal that AHR can act as an ROS sensor to mediate chemoresistance, thus providing a potential strategy to reverse chemoresistance in patients with cancer.

[1]  Hua-Chuan Zhang,et al.  Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells , 2023, Science Translational Medicine.

[2]  T. Haarmann-Stemmann,et al.  Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway. , 2022, Biochemical pharmacology.

[3]  Hua-Chuan Zhang,et al.  TCR activation directly stimulates PYGB-dependent glycogenolysis to fuel the early recall response in CD8+ memory T cells. , 2022, Molecular cell.

[4]  C. Shan,et al.  The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance , 2022, Life.

[5]  B. Spiegelman,et al.  Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation. , 2021, Cell metabolism.

[6]  Xianming Deng,et al.  Glycogen accumulation and phase separation drives liver tumor initiation , 2021, Cell.

[7]  X. Coumoul,et al.  Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor. , 2021, Annual review of pharmacology and toxicology.

[8]  Hua-Chuan Zhang,et al.  Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program , 2021, Cancer Research.

[9]  B. Dong,et al.  IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor , 2021, Nature Immunology.

[10]  Hua-Chuan Zhang,et al.  Beyond energy storage: roles of glycogen metabolism in health and disease , 2020, The FEBS journal.

[11]  S. Shen,et al.  Persistent Cancer Cells: The Deadly Survivors , 2020, Cell.

[12]  Y. Chai,et al.  Redox Regulation by Protein S-Glutathionylation: From Molecular Mechanisms to Implications in Health and Disease , 2020, International journal of molecular sciences.

[13]  K. Tew,et al.  Oxidative Stress in Cancer. , 2020, Cancer cell.

[14]  X. Tong,et al.  The Role of the Pentose Phosphate Pathway in Diabetes and Cancer , 2020, Frontiers in Endocrinology.

[15]  H. Itoh,et al.  Biochemical properties of human full-length aryl hydrocarbon receptor (AhR). , 2020, Journal of biochemistry.

[16]  Hua-Chuan Zhang,et al.  Glycogen metabolism regulates macrophage-mediated acute inflammatory responses , 2020, Nature Communications.

[17]  Hua-Chuan Zhang,et al.  Glycogen metabolism regulates macrophage-mediated acute inflammatory responses , 2020, Nature Communications.

[18]  Neil Vasan,et al.  A view on drug resistance in cancer , 2019, Nature.

[19]  Wenhao Zhang,et al.  The Protein Phosphatase 1 Complex Is a Direct Target of AKT that Links Insulin Signaling to Hepatic Glycogen Deposition. , 2019, Cell reports.

[20]  T. McGaha,et al.  The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment. , 2018, Trends in immunology.

[21]  Le Zhang,et al.  STAT3/p53 pathway activation disrupts IFN-&bgr;–induced dormancy in tumor-repopulating cells , 2018, The Journal of clinical investigation.

[22]  D. Pang,et al.  Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111 , 2018, Cell Death & Disease.

[23]  Xuetao Cao,et al.  A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells , 2017, Nature Cell Biology.

[24]  G. Shulman,et al.  Regulation of hepatic glucose metabolism in health and disease , 2017, Nature Reviews Endocrinology.

[25]  T. Zhao,et al.  Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells , 2017, Nature Communications.

[26]  Martin Egli,et al.  Recent Structural Insights into Cytochrome P450 Function. , 2016, Trends in pharmacological sciences.

[27]  Hongwei Gong,et al.  Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles , 2016, Cell Research.

[28]  S. Koo,et al.  Regulation of glucose metabolism from a liver-centric perspective , 2016, Experimental & Molecular Medicine.

[29]  L. Agius Role of glycogen phosphorylase in liver glycogen metabolism. , 2015, Molecular aspects of medicine.

[30]  Slobodan Rendic,et al.  Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals , 2014, Chemical research in toxicology.

[31]  G. Perdew,et al.  Aryl hydrocarbon receptor ligands in cancer: friend and foe , 2014, Nature Reviews Cancer.

[32]  P. Jiang,et al.  Regulation of the pentose phosphate pathway in cancer , 2014, Protein & Cell.

[33]  B. Stockinger,et al.  The aryl hydrocarbon receptor: multitasking in the immune system. , 2014, Annual review of immunology.

[34]  F. Quintana,et al.  Aryl Hydrocarbon Receptor Control of Adaptive Immunity , 2013, Pharmacological Reviews.

[35]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[36]  M. Schwab,et al.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.

[37]  C. Hoppel,et al.  Oxidation of Fatty Acids Is the Source of Increased Mitochondrial Reactive Oxygen Species Production in Kidney Cortical Tubules in Early Diabetes , 2012, Diabetes.

[38]  Jing Liu,et al.  Soft fibrin gels promote selection and growth of tumourigenic cells , 2012, Nature Materials.

[39]  A. Depaoli-Roach,et al.  Glycogen and its metabolism: some new developments and old themes. , 2012, The Biochemical journal.

[40]  Bryan C Dickinson,et al.  Chemistry and biology of reactive oxygen species in signaling or stress responses. , 2011, Nature chemical biology.

[41]  H. Weiner,et al.  Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell–like and Foxp3+ regulatory T cells , 2010, Nature Immunology.

[42]  M. Toledano,et al.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis , 2007, Nature Reviews Molecular Cell Biology.

[43]  Vlada B Urlacher,et al.  Cytochrome P450 monooxygenases: perspectives for synthetic application. , 2006, Trends in biotechnology.

[44]  L. Poole Measurement of Protein Sulfenic Acid Content , 2004, Current protocols in toxicology.

[45]  C. Newgard,et al.  Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1. , 2000, Diabetes.

[46]  A. Saltiel,et al.  Role of Protein Targeting to Glycogen (PTG) in the Regulation of Protein Phosphatase-1 Activity* , 1997, The Journal of Biological Chemistry.

[47]  E. Glover,et al.  Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. , 1976, The Journal of biological chemistry.

[48]  D. Liebler,et al.  Use of dimedone-based chemical probes for sulfenic acid detection methods to visualize and identify labeled proteins. , 2010, Methods in enzymology.